To evaluate if Hb changes modulate the predicative role of anemia in cancer mortality, we analyzed the association between anemia, which was indicated by the average Hb level measured within six months after diagnosis of less than 12 g/dL, and the overall survival of all cancer patients in this study stratified by different levels of |∆Hb|. This evidence concerns the gene GSTM1 and anemia (phenotype).